Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CNTX | US
0.01
0.41%
Healthcare
Biotechnology
30/06/2024
30/08/2024
2.46
2.47
2.49
2.43
Context Therapeutics Inc. a biopharmaceutical company develops products for the treatment of solid tumors in the United States. It develops CLDN6xCD3 bsAb an anti-CD3 x anti-Claudin 6 antigen bispecific monoclonal antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular Inc. for the development of an anti-claudin 6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia Pennsylvania.
View LessValue Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
18.4%1 month
46.0%3 months
70.5%6 months
82.8%-
-
1.82
-
-
1.60
-
-
-20.01M
184.50M
184.50M
-
-
-
-
-29.68
21.29
2.80
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.29
Range1M
0.74
Range3M
1.40
Rel. volume
0.32
Price X volume
66.47K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Gossamer Bio Inc | GOSS | Biotechnology | 0.8778 | 198.58M | 1.96% | n/a | 243.93% |
Vaxart Inc | VXRT | Biotechnology | 0.8669 | 197.17M | 1.75% | n/a | 28.91% |
Regulus Resources Inc | RGLSF | Biotechnology | 1.53 | 197.06M | 2.00% | n/a | 0.00% |
Caribou Biosciences Inc. | CRBU | Biotechnology | 2.16 | 195.18M | 2.37% | n/a | 8.80% |
XBiotech Inc | XBIT | Biotechnology | 6.4 | 194.96M | -7.91% | n/a | 5.08% |
Mersana Therapeutics Inc | MRSN | Biotechnology | 1.58 | 193.83M | 3.95% | n/a | 383.37% |
MOLECULAR PARTNERS AG | MOLN | Biotechnology | 5.68 | 188.47M | -12.35% | n/a | 1.96% |
Compugen Ltd | CGEN | Biotechnology | 2.1 | 188.03M | 3.45% | n/a | 5.19% |
Inovio Pharmaceuticals Inc | INO | Biotechnology | 7.22 | 187.46M | -1.37% | n/a | 13.42% |
Greenwich LifeSciences Inc | GLSI | Biotechnology | 14.02 | 184.29M | -1.54% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 53.7 | 152.52M | -0.37% | 8.42 | 71.47% |
Saga Communications Inc | SGA | Broadcasting - Radio | 14.72 | 92.17M | -2.06% | 14.72 | 7.10% |
Urban One Inc | UONEK | Broadcasting - Radio | 1.38 | 76.89M | 5.34% | n/a | 268.43% |
Emmis Communications Corporation | EMMS | Broadcasting - Radio | 4.7 | 57.98M | -1.05% | n/a | 54.59% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 3.68 | 39.85M | -1.12% | n/a | 54.96% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 2.34 | 28.51M | 13.04% | n/a | 16.03% |
ILAG | ILAG | Building Products & Equipment | 1.25 | 22.57M | 6.84% | n/a | 5.48% |
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 0.6131 | 18.67M | -4.20% | n/a | 204.46% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2495 | 3.93M | 5.94% | n/a | 0.00% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.391 | 3.72M | -6.28% | n/a | 19.98% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 1.60 | 0.97 | Expensive |
Ent. to Revenue | - | 3,681.29 | - |
PE Ratio | - | 39.83 | - |
Price to Book | 1.82 | 14.54 | Cheaper |
Dividend Yield | - | 2.19 | - |
Std. Deviation (3M) | 70.48 | 76.13 | Par |
Debt to Equity | - | -2.05 | - |
Debt to Assets | - | 0.25 | - |
Market Cap | 184.50M | 4.04B | Emerging |